Back to Search Start Over

Clinical effects of SGLT2 inhibitors in seven persons with HNF1A‐MODY (MODY3).

Authors :
Maagensen, Henrik
Hædersdal, Sofie
Krogh, Jesper
Hansen, Torben
Knop, Filip Krag
Thuesen, Anne Cathrine Baun
Vilsbøll, Tina
Source :
Diabetic Medicine. Oct2024, Vol. 41 Issue 10, p1-4. 4p.
Publication Year :
2024

Abstract

The article focuses on the use of SGLT2 inhibitors in patients with HNF1A-MODY, a type of monogenic diabetes. Topics include the typical treatment regimen for HNF1A-MODY, the observed clinical outcomes from adding SGLT2 inhibitors to existing therapies, and the specific HNF1A genetic variants found in the study participants.

Subjects

Subjects :
*EMPAGLIFLOZIN
*HOSPITAL care
*TRANSCRIPTION factors
*MATURITY onset diabetes of the young
*SULFONYLUREAS
*GENE expression
*INSULIN resistance
*SODIUM-glucose cotransporter 2 inhibitors
*GLOMERULAR filtration rate

Details

Language :
English
ISSN :
07423071
Volume :
41
Issue :
10
Database :
Academic Search Index
Journal :
Diabetic Medicine
Publication Type :
Academic Journal
Accession number :
180376174
Full Text :
https://doi.org/10.1111/dme.15387
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details